Neil Versel
Neil Versel is an editor at GenomeWeb. He covers the life science and healthcare informatics markets.
Articles Authored by Neil Versel
Bioinformatics Startup Geneyx Builds Business on Whole-Genome, Long-Read Sequencing Analysis
Premium
A recent data-integration partnership with Oxford Nanopore mirrors one that Israel-based Geneyx already has with PacBio in pursuit of higher diagnostic yields.
With $50M Investment in MOSAIC Project, Owkin Seeks to Become Cancer 'Drug Discovery Enterprise'
Premium
The MOSAIC research coalition brings together Owkin, NanoString, and European and US institutions to create a massive spatial omics dataset in pursuit of novel cancer biomarkers
The National Council for Prescription Drug Programs (NCPDP) seeks to position pharmacists at the center of PGx management and update existing pharmacy data standards.
The Global Alliance for Genomics and Health also wants to take on more driver projects as it looks to promote standards-based precision medicine.
Broad Institute Data Sciences Platform Aims to Provide Infrastructure, Tools for Global Genomics
Premium
The DSP's Terra cloud is just one part of a massive data operation as the Broad looks to AI and long-read sequencing to support functional and clinical genomics.
Originally a DTC genomics software company, SelfDecode is starting to explore commercial and partnerships to create laboratory-developed tests.
The firm only offered vague generalities about the ongoing integration of Lemonaid and pointed to "more rollouts" in the second half of the year.
The artificial intelligence-driven platform is competing with Amazon Omics to support multiomic big data in healthcare and life sciences.
The centerpiece of the new features is Ready2Run, a collection of public and private genome analysis and interpretation pipelines that can be accessed through a single API call.
SomaLogic Q1 Revenues Fall 11 Percent but Beat Wall Street Consensus
Six weeks after a management shakeup, the proteomics firm is looking for unspecified "inorganic" opportunities to become profitable.